Директор NewGenIVF Group приобрела на 2,5 млн долларов акций компании

NewGenIvf Group Limited (NASDAQ:NIVF – Get Free Report) Director Kong Yiu Cheung purchased 500,000 shares of the business’s stock in a transaction dated Thursday, June 18th. The shares were purchased at an average price of $1.33 per share, with a total value of $665,000.00. Following the acquisition, the director directly owned 1,222,223 shares in the company, valued at approximately $1,625,556.59. The trade was a 69.23% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Kong Yiu Cheung also recently made the following trade(s): - On Monday, July 27th, Kong Yiu Cheung acquired 2,500,000 shares of NewGenIvf Group stock. The shares were acquired at an average cost of $1.00 per share, with a total value of $2,500,000.00. NewGenIvf Group Price Performance NewGenIvf Group stock opened at $1.33 on Wednesday. NewGenIvf Group Limited has a 1 year low of $1.15 and a 1 year high of $1,539.00. The company has a debt-to-equity ratio of 0.16, a current ratio of 3.12 and a quick ratio of 2.98. The company’s 50 day simple moving average is $2.96 and its 200-day simple moving average is $11.34. Analyst Upgrades and Downgrades Read Our Latest Stock Analysis on NewGenIvf Group About NewGenIvf Group NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures. NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation. Featured Stories Receive News & Ratings for NewGenIvf Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NewGenIvf Group and related companies with MarketBeat.com's FREE daily email newsletter.